What We Do

Services

In the Press

May 17, 2018

New Blood Test Rapidly Detects Signs of Pancreatic Cancer

A new diagnostic test developed by researchers at UC San Diego shows promise for detecting pancreatic disease earlier.




May 10, 2018

We Need You: Join All of Us to Advance Precision Medicine

UC San Diego Health researchers call for volunteers to participate in landmark precision medicine research effort, including Dr. Razelle Kurzrock.




May 7, 2018

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC

This is the first such study in this group,with findings running counter to prior research in other cancers, with senior author of the study Dr. Rana McKay.




April 25, 2018

Breathe easier with lung cancer screenings

UC San Diego Health established a new lung cancer screening program to help current and former smokers determine their risk for lung cancer. The program is led by Dr. Mark Onaitis.




April 20, 2018

Keytruda Performs Well in Latest Lung Cancer Clinical Trials

The immunotherapy drug has been successful in treating other cancers and the latest trials provide hope for people battling lung cancer. The piece features Dr. Sandip Patel.




April 12, 2018

What You Need to Know About Head and Neck Cancer

Cancer.Net has a new blog about Head and Neck Cancer written by Dr. Kathryn Gold.




April 9, 2018

Cutting-edge cancer drug hobbled by diagnostic test confusion

Physicians struggle to identify which patients are likely to respond to a recently approved therapy, with input from Dr. Razelle Kurzrock.




April 5, 2018

Bryce Olson Wants To Raise Awareness About Precision Medicine. His Rallying Cry: 'Sequence Me'

Bryce Olson's story and collaboration with UC San Diego Moores Cancer Center is told in Forbes, featuring his collaboration team that includes Ida Deichaite, PhD, Director of Industry Relations, Pablo Tamayo, PhD, and Christina Jamieson, PhD.




April 2, 2018

Surprise! Medical Research a Big Winner in New Federal Budget

Despite the president’s threats to cut funding, Congress approved budget increases for cancer, Alzheimer’s, and other medical research. The article features research by Dr. Ezra Cohen.




April 2, 2018

Even DNA that Doesn’t Encode Genes Can Drive Cancer

A trove of previously overlooked genetic mutations play a role in cancer, providing nearly 200 new opportunities for molecularly targeted therapeutics, in a study by senior author Trey Ideker, PhD.




March 28, 2018

Local Realtors and restaurants team up for fundraiser

Local real estate agents and Conejo Valley restaurants are participating in an April effort to raise funds for research into a rare cancer of the gastrointestinal tract, one that has afflicted a 2017 Westlake High School graduate over the past year, and will support research being done by Dr. Jason Sicklick.




March 25, 2018

Expert Point of View: Ezra Cohen, MD, PhD

Discussant for the abstract, Dr. Ezra Cohen pointed out that although this subgroup may be responsive to checkpoint inhibition, it may not necessarily be anti–programmed cell death protein 1 (anti–PD-1) therapy.




March 20, 2018

Dr. Sacco on Ongoing Trials for Chemoradiation in Head and Neck Cancer

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses ongoing trials investigating chemoradiation for patients with head and neck cancer.




March 16, 2018

Comprehensive Breast Health Center Expands at UC San Diego Health

The Comprehensive Breast Health Center is located within the Koman Family Outpatient Pavilion at UC San Diego Health, and the facility offers women and men new options for breast cancer care.




March 9, 2018

Tissue-agnostic cancer drug pipeline grows, despite doubts

The FDA could soon approve the first drug developed explicitly for a tissue-agnostic cancer indication, but biological complexity may limit this approach. This Nature Review Drug Discovery article features Dr. Razelle Kurzrock.




March 9, 2018

UC San Diego Researchers Launch Combination Drug Trial to Eradicate B-Cell Malignancies

It’s hoped the two new drugs in tandem can fully clear leukemias and other blood cancers. This trial consists of PI Dr. Catriona Jamieson, was developed by Dr. Tom Kipps, and team member Dr. Michael Choi.




March 2, 2018

Watering Dandelions with Chemo Bath

UC San Diego Health milestone: 500 patients undergo HIPEC while ovarian cancer meets new foe, featuring HIPEC team members Drs. Andy Lowy, Jula Veerapong, Joel Baumgartner, and Kaitlyn Kelly.




March 1, 2018

Stand Up To Cancer dream team strives for ‘active interception’ of pancreatic cancer

The Stand Up To Cancer foundation has formed a “dream team” to identify new ways to detect pancreatic cancer at earlier stages when it is most amenable to treatment, which includes UC San Diego Moores Cancer Center.




March 1, 2018

Former SDSU Basketball Star Opens Up About Cancer Battle

Tammy Blackburn leads a jam-packed life with no desire to slow down for the "Big C." Her treatment is at UC San Diego Moores Cancer Center.




February 28, 2018

Not Enough People With HIV Receive Proper Cancer Treatment

Recognizing this threat to the health and longevity of the HIV population, the National Comprehensive Cancer Network (NCCN) has issued new guidelines on treating cancer among them, with Panel Co-Chair Dr. Erin Reid.




February 23, 2018

Cancer therapy poised for rapid advances, noted researcher says

Duane Roth Endowed Award Lecture recipient Dr, Carl June, a pioneer in CAR T cell therapy, presented information from research yet to be published pointing to advances in immunotherapy on Thursday February 22, 2018 at the Translational Oncology symposium.




February 23, 2018

Scripps Research CEO outlines path to financial sustainability

Translational Oncology Symposium Keynote Speaker Dr. Peter Schultz outlined progress towards financial independence within three to five years at the event on Thursday February 22, 2018.




January 31, 2018

Frontline Cancer: Precision medicine having an impact on clinical trials

Clinical trials are the final step before a new drug or treatment is approved for broad use in patients, with many at UC San Diego Moores Cancer Center.




January 8, 2018

Celgene to buy San Diego cancer-drug maker Impact for $1.1B

Celgene Corp. agreed to buy closely held San Diego-based Impact Biomedicines for $1.1 billion upfront to gain an experimental blood cancer treatment, with founder Dr. Catriona Jamieson.




January 4, 2018

Physical activity may improve cognitive function among breast cancer survivors

Increased physical activity improved cognitive function among a cohort of breast cancer survivors who were 2 years beyond surgery, according to study results by senior author Sheri Hartman,.




December 20, 2017

Aggressive Treatment of Early Lung Cancer Improves Survival

Aggressive surgery for early-stage NSCLC results in longer survival than more moderate surgery and an increasingly popular radiation therapy approach, according to a study by senior author James Murphy, MD.




December 6, 2017

Fate Therapeutics, UC San Diego Launch CAR NK Cancer Immunotherapy Collaboration

The collaboration will develop off-the-shelf, chimeric antigen receptor (CAR)-targeted natural killer (NK) cell cancer immunotherapies, led by Dan Kaufman, MD, PhD.




December 5, 2017

Dynavax Co-founder Takes Long View on Vaccine Development

The FDA approved a new haptatis B vaccine last month, the first Dynavax product to win FDA approval, founded by Dr. Dennis Carson.




December 5, 2017

In Multiple Myeloma, High Levels of Enzyme ADAR1 are Associated with Reduced Survival

Inhibiting ADAR1 in experimental models reduced disease recurrence in an approach known as “precision regenerative medicine”, in a Nature Communications paper with senior authors Drs. Leslie Crews and Catriona Jamieson.




December 1, 2017

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

UC San Diego researchers will specifically target acute myeloid leukemia, awarded to Drs. Dan Kaufman and Catriona Jamieson.




December 1, 2017

New Cancer Management Guidelines for Care of People with Kaposi Sarcoma

New NCCN guidelines for patients living with HIV who develop AIDS-related Kaposi sarcoma were developed with leadership by Panel Co-Chair Dr. Erin Reid.




November 30, 2017

Vulnerability Identified for Subtypes of Glioblastoma

Precision medicine approach may give previously tested drug a second chance, in a Cancer Cell paper led by senior author David Cheresh, PhD.




November 27, 2017

Immunotherapy Research for Head and Neck Cancers Gets Boost from V Foundation Grant

A team of researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years, led by Judy Varner, PhD.




November 21, 2017

Frontline Cancer: A one-size-fits-all strategy doesn't work fighting cancer

How will the funding for the the U.S. Cancer Moonshot initiative and 21st Century Cures Act be utilized in research, treatment, and prevention, questions Dr. Scott Lippman.




November 14, 2017

A New Strategy for Prevention of Liver Cancer Development

A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine, featuring senior author Gen-Sheng Feng, PhD.




November 8, 2017

Precision medicine clinical decision support system bests oncologists at picking cancer treatment

A prominent academic medical center, a supercomputer and a California start-up came together to determine the best regimen for a patient after doctors had tried four previous times, featuring Dr. Razelle Kurzrock.




November 8, 2017

How Chronic Inflammation Tips the Balance of Immune Cells to Promote Liver Cancer

Study explains success of some types of cancer immunotherapy, provides new targets for the development of additional immunotherapies, with senior author Dr. Michael Karin.




November 1, 2017

The Forever War

A new Lancet commission report is both expansive and remarkably detailed, providing a roadmap with directions and 13 priority areas related to, among other things, early detection, immunotherapy, imaging, surgery, drug access, treatment disparities and prevention for cancer, says Dr. Scott Lippman.




October 27, 2017

What a Person's Immune System Says About Their Cancer

UC San Diego School of Medicine researchers have discovered early evidence that the genetics of a person’s immune system may help predict what that person’s cancer might look like, molecularly speaking, with lead author Hannah Carter, PhD.




October 27, 2017

Discussing Treatment Options in Thyroid Cancer

The hype of personalized medicine now is making its way into thyroid cancer, says Dr. Gregory Daniels, and a genetic-based approach to treatment may be in the future for this disease.




October 27, 2017

Recurrent Head and Neck Cancer: Continuing Encouraging Results for Pembrolizumab

Improved outcomes in subset of recurrent head and neck cancer patients with PD-LI-expressing tumors featuring the study's lead author Dr. Ezra Cohen.




October 26, 2017

UC San Diego Health Researchers Help Launch Second Pancreas Cancer “Dream Team”

New 4-year, $7-million collaborative grant will focus on preventing the deadly disease, featuring Drs. Scott Lippman and Andy Lowy.




October 26, 2017

Stand Up To Cancer Launches Four Teams on "Cancer Interception" To Detect and Treat Cancer at Earliest Stages

SU2C, the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and American Lung Association's LUNG FORCE Commit $16.6 Million to New Approach, featuring co-leader Dr. Scott Lippman.




October 25, 2017

How scientists hope to treat diseases by editing our RNA

Opening a new chapter in genetic medicine, scientists have devised a method of gene editing that can turn the protein-production machinery of certain cells on and off at will, featuring commentary by Dr. Catriona Jamieson.




October 24, 2017

Local Couple Donates $1M to UCSD for Development of Cancer Vaccines

A local philanthropic couple has donated $1 million to UC San Diego in support of a clinical trial aimed at developing personalized cancer vaccines that could help patients fight the disease using their own immune systems, led by Dr. Ezra Cohen.




October 20, 2017

Cutting Carbs Won't Save You From Cancer

Research shows high levels of glucose could overstimulate the production of certain proteins often found in tumors, and those proteins could cause cancer cells to grow and multiply faster, featuring Christine Zoumas, MS, RD.




October 18, 2017

Frontline Cancer: Cancer Consortium links work of five UC cancer centers

The new University of California Cancer Consortium is an alliance of UC's five cancer centers at UC Davis, UC Irvine, UCLA, UCSF and, Moores Cancer Center at UC San Diego Health, introduced by Dr. Scott Lippman.




October 18, 2017

Ultra-personal therapy: Gene tumor boards guide cancer care

Cancer patients increasingly are having their care guided by gene tumor boards, a new version of the hospital panels that traditionally decided whether surgery, radiation or chemotherapy would be best, featuring Dr. Razelle Kurzrock.




October 16, 2017

In early study, rare tumors respond to precision therapy

Treatment of rare tumors can be improved with a “precision medicine” approach of matching treatment to the molecular profile of the cancers, according to a preliminary study from UCSD researchers, first author Dr. Shumei Kato and senior author Dr. Razelle Kurzrock.




October 13, 2017

Abandoned blood cancer drug resurrected by San Diego startup

An experimental blood cancer drug shelved for safety concerns is being brought back to clinical development, and pushed by Dr. Catriona Jamieson who treated patients with the drug.




October 10, 2017

Your fitness tracker might hold the cure to cancer

A recent UCSD Study led by Sheri Hartman, PhD, looked at the impact of exercise on the brain function of breast cancer survivors, and found physical activity significantly improved cognitive processing — all via the data collected from the Fitbit on their wrist.




October 10, 2017

Powered by Chemo: Patient with Advanced Pancreatic Cancer Tackles Ironman Triathlon

On October 14, stage IV pancreatic cancer patient Mike Levine will compete in the Ironman World Championship, cheered on by his doctor, pancreatic cancer expert Dr. Paul Fanta.




October 9, 2017

Liquid Biopsy May Be New Way to Detect Liver Cancer Earlier, Easier

Researchers discover blood-based DNA test for effective, minimally invasive diagnosis of hepatocellular carcinoma, featuring Dr. Scott Lippman and Kang Zhang, MD, PhD.




October 3, 2017

New Technology Enables Shorter Radiation Treatment Time for Patients

Patients at UC San Diego Health in need of radiation therapy now have access to the next generation of radiation treatment technology, featuring Dr. Arno J. Mundt.




October 3, 2017

Breast cancer deaths continue to decline but racial disparities persist

Breast cancer death rates continue to drop nationwide, but the disease remains deadliest for African-American women, according to the latest report from the American Cancer Society, featuring Dr. Maria Elena Martinez.




October 1, 2017

DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

In a first-of-its-kind study, UCSD MCC researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies, with authors Dr. Yulian Khagi and Dr. Razelle Kurzrock.




September 29, 2017

Ride for a Reason

Community leaders join the fight against cancer with Padres Pedal the Cause, featuring Moores Cancer Center.




September 27, 2017

Editing Genes One by One Throughout Colorectal Cancer Cell Genome Uncovers New Drug Targets

A study, published September 27 in Cancer Research, provides potential new drug targets for KRAS-driven cancers, with senior author Dr. Tariq Rana.




September 22, 2017

The Zika Virus May Someday Be Used to Treat Incurable Brain Cancer—Here’s How

Zika has caused a lot of grief and concern, but researchers think they may be able to squeeze some good out of this vicious virus, featuring Dr. Jeremy Rich.




September 20, 2017

Ironman training partners racing cancer to the finish line

Dr. Paul Fanta used molecular research to tailor a treatment for Ironman runner Mike Levine, a pancreatic cancer patient.




September 19, 2017

Keytruda Better than Standard Treatment for Advanced Head and Neck Cancer, Keynote-040 Study Shows

Keytruda (pembrolizumab) may be more beneficial than standard therapy for patients whose head and neck cancer has spread or returned after a first round of chemotherapy, featuring Dr. Ezra Cohen.




September 19, 2017

The big question: Will cancer immune therapy work for me?

Immunotherapy treatments are expensive, have side effects, work for only about one-quarter of patients, and are successful in patients with genetic mutations, says Dr. Razelle Kurzrock.




September 19, 2017

Brain Powered: Increased Physical Activity Among Breast Cancer Survivors Boosts Cognition

In the journal Cancer researchers report in a pilot study of 87 female breast cancer survivors that an increase in physical activity more than doubled the women’s post-treatment mental processing speed, with first author Sheri Hartman, PhD.




September 15, 2017

Better Calculating the Aggressiveness of Prostate Cancer

Scientists are looking for more and better ways to identify the prostate cancers that are most likely to become aggressive, featuring Dr. Christopher Kane.




September 13, 2017

Researchers Develop New Strategy to Target KRAS Mutant Cancer

In a new study, with senior author David Cheresh, PhD published this month in Cancer Discovery, researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.




September 12, 2017

UC Cancer Centers Join Forces To Fight One Of California’s Top Killers

The University of California’s five cancer centers are joining forces to tackle some of the toughest challenges of a disease that kills 60,000 Californians a year and costs $14 billion in medical care and lost workplace productivity, featuring Dr. Scott Lippman.




September 7, 2017

Metastatic melanoma patients dramatically respond to combo cancer therapy

Early clinical trial results of a therapy combining a cancer-killing virus and an immune-stimulating drug for metastatic melanoma are showing dramatic results, featuring Dr. Gregory Daniels.




September 5, 2017

Zika Virus Targets and Kills Brain Cancer Stem Cells

In vitro and animal studies suggest virus that causes devastating neurological damage in developing fetuses might be new tool for improving survival rates in patients with glioblastomas, featuring Dr. Jeremy Rich.




September 1, 2017

Unmasking a Silent Killer: Ovarian Cancer

Ovarian cancer has been termed the silent killer because its presenting symptoms are often mistaken for other benign conditions, particularly the ones that affect the gastrointestinal system, or simply changes in a woman's body as she ages, featuring Dr. Ramez Eskander.




September 1, 2017

Doctors want to give their cancer patients every chance. But are they pushing off hard talks too long?

Doctors who counsel immunotherapy, experts say, are postponing conversations about palliative care and end-of-life wishes with their patients — sometimes, until it’s too late, featuring Drs. Eric Roeland and Sandip Patel.




August 24, 2017

State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial

UC San Diego researchers will combine an experimental drug with an approved drug in effort to boost remission rates and long-term cancer control, led by Dr. Tom Kipps, featuring Drs. Catriona Jamieson and Dennis Carson.




August 24, 2017

GPS Maps for Cancer

Pablo Tamayo, PhD and his team developed Onco-GPS, a computational method to organize individual tumor samples with shared cancer-causing alterations onto a reference map defined by their underlying cellular functions.




August 24, 2017

Setback in prostate cancer battle

Harms from PSA-based screenings may outweigh the benefits, commented Dr. Karim Kader.




August 22, 2017

Public Health Benefits When Patients with Advanced Cancer Receive Palliative Care

UCSD researchers including senior author Dr. James Murphy published findings of a study that is the first to show a relationship between palliative care and end-of-life care in the United States at a population-based level.




August 24, 2017

Writing through pain: A cancer survivor guides patients with pen and paper

A cancer survivor has launched writing programs for patients and survivors at California health care facilities including Moores Cancer Center.




August 18, 2017

GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed

MCC Researchers including Dr. Jason Sicklick, in collaboration with Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that the duodenal-jejunal flexure shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.




August 16, 2017

Do You Need to Get a Lung Cancer Screening?

To slow the lung cancer epidemic, a new campaign from the American Lung Association highlights the lifesaving potential of lung cancer screenings, featuring Dr. Mark Onaitis.




August 15, 2017

Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

Using fragments of circulating tumor DNA in blood, UCSD researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), featuring Dr. Razelle Kurzrock.




August 13, 2017

Poison drummer Rikki Rocket to attend surfing competition

The drummer for the 1980s glam metal band Poison is scheduled to be the guest speaker Sunday at an annual surfing invitational and luau to benefit the UC San Diego Moores Cancer Center.




August 1, 2017

Female scientists share their breakthroughs at Salk Institute lecture in La Jolla

A panel of enthusiastic medical scientists spoke at the “Women Innovators in Human Health: From Bench to Beside” conference at Salk Institute, featuring Dr. Razelle Kurzrock.




July 31, 2017

Padres Pedal the Cause for Cancer Research

Padres Pedal the Cause announced the awarding of $750,000 to fund 12 collaborative research grants to three National Cancer Institute-Designated Cancer Centers in San Diego.




July 23, 2017

Cancer stem cells target of new grant to UCSD scientists

California’s stem cell agency has awarded $5.8 million to UC San Diego researchers to develop a new variation of cancer immunotherapy, led by Dr. Ezra Cohen.




July 21, 2017

Facing deadly cancer, Vista woman plans her wedding

Rather than planning her funeral, the 31-year-old Vista woman immediately started planning her wedding, treated by oncologist Dr. Kathryn Gold.




July 21, 2017

10 physicians win NCI Cancer Clinical Investigator Team Leadership Awards

MCC Investigator Dr. Eric Roeland joined 9 investigators nationwide to receive the NCI’s Cancer Clinical Investigator Team Leadership Awards.




July 21, 2017

Patient Selection in Treating HNSCCs

OncLive Insights From Dr. Ezra Cohen.




July 20, 2017

UCSD advancing glioblastoma brain cancer research

This week many Americans are hearing the world 'glioblastoma' for the first time. Dr. Jeremy Rich is leading UCSD's new treatments for this deadly form of cancer.




July 20, 2017

CIRM Approves $5.8 Million Grant for CAR-T Therapy that Targets Cancer Stem Cells

Lab-modified immune cells would be genetically boosted to improve ability to target and kill multiple cancers, with teams headed by Dr. Ezra Cohen and Dr. Tom Kipps.




July 19, 2017

Dr. Kane on Challenges Facing Genetic Testing in Prostate Cancer

Dr. Christopher Kane discusses challenges facing genetic testing for patients with prostate cancer.




July 6, 2017

Tempus to Assist University of California San Diego In Personalized Medicine Initiative

Tempus will provide Moores Cancer Center at UC San Diego Health with molecular sequencing, analysis and decision support tools to enable further research on immune checkpoint inhibitors across cancer types.




July 3, 2017

Cancer, redefined

The first approval of a tissue-agnostic treatment signals change in how oncology drugs are tested and used, featuring Dr. Razelle Kurzrock.




June 30, 2017

Local Venture Capitalist Looks To The Future Of Healthcare

Dr. Razelle Kurzrock helped to develop the algorithms for oncologists at CureMatch.




June 28, 2017

Vivace uncloaks with $40M, U.S.-China backing for cancer trials

Vivace Therapeutics has emerged from stealth with two funding rounds to the tune of $40 million as it looks to speed up work on the Hippo-YAP signaling pathway, with Kun-Liang Guan, PhD.




June 27, 2017

Harnessing Cancer’s Methylation Footprint for More Precise Diagnosis and Prognosis

The new study was published online in PNAS with Co-Senior Author Michael Karin, PhD along with collaborators at UCSD School of Medicine and colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China.




June 7, 2017

Review of Appendix Cancer Cases Finds Over Diagnosis

​Lesions of the appendix are being over diagnosed as invasive cancer, report Dr. Andy Lowy and researchers in a paper published June 7 in the journal PLOS ONE.




June 6, 2017

Cancer Cells Send Signals Boosting Survival and Drug Resistance in Other Cancer Cells

Dr. Maurizio Zanetti reports that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.




June 6, 2017

Abreos Biosciences Raises $1.2 Million

Founded in 2013 at UC San Diego by Dr. Bradley Messmer and Dr. Tom Kipps, Abreos is developing point-of-care devices that monitor the levels of biologic drugs in patients for precision dose guidance.




June 4, 2017

Regional cancer task force releases initial data

Locally, communities have joined together to form a Regional Cancer Treatment Task Force to research and address cancer-related issues.




June 2, 2017

Half of all cancer deaths are avoidable. Follow these key prevention steps.

Features MCC Investigators Drs. Georgia Sadler and Samir Gupta.




May 31, 2017

In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions

Researchers at UCSD published a 168-patient study on discordance in early 2016, and they hope to publish soon two more studies with about 300 patients combined.




May 31, 2017

UC San Diego hires renowned brain cancer expert Jeremy Rich

UC San Diego has recruited Dr. Jeremy Rich, a renowned Cleveland Clinic physician-scientist who grapples with the notoriously difficult problem of understanding and treating brain tumors.




May 31, 2017

Frontline Cancer: Genetic background can provide clues about possible future tumors

The research article was published in the journal Cancer Discovery earlier this year, with authors Hannah Carter, PhD and Trey Ideker, PhD.




May 30, 2017

We’re Doing Something About Colorectal Cancer Disparities

Screening for colorectal cancer is a true public health success story, featuring María Elena Martínez, PhD.




May 26, 2017

Cancer scientist tries to help others as he battles his own Stage 4 cancer

Tom Marsilje, who has Stage 4 colorectal cancer, created a website to help people make sense of clinical trials for the disease. Features Dr. Ezra Cohen.




May 25, 2017

Are basket trials the most appropriate method to capitalize on increased rates of genomic sequencing?

Dr. Razelle Kurzrock argues that it is not new and is, ultimately, a poor fit for the genomic complexity and intertumor heterogeneity uncovered by sequencing.




May 23, 2017

Future of Immunotherapy in Head and Neck Cancer May Be in Combinations

The promise of immune-based approaches was discussed during an OncLive® Peer Exchange panel, A New Era for Treatment of Advanced Head and Neck Cancer, which was moderated by Dr. Ezra Cohen.




May 22, 2017

San Diego woman: Stage zero cancer treatment deformed me

A San Diego woman is trying to bring awareness to stage zero breast cancer and what she believes was a rush to treatment, featuring Dr. Anne Wallace.




May 22, 2017

New painkiller discovered in cancer cells

This painkiller strongly inhibits acute and chronic pain in mouse models of melanoma, according to a study published Monday in Nature Neuroscience.




May 14, 2017

Blocking a tumor suppressor gene actually slows down one kind of glioblastoma

Tumor suppressor genes, as their name implies, prevent tumors. Their failure can lead to cancer. But a study led by UCSD scientists demonstrated that, in one kind of glioblastoma, inhibiting a tumor suppressor gene, called DAXX actually slows down the cancer.




May 9, 2017

UCSD Receives Significant Charitable Donation from Point Loma Rotary Club to Advance Pancreatic Research

Genetic testing for patients with prostate cancer is poised to have a major impact on both screening and treatment selection; however significant advances are still needed, according to Dr. Christopher Kane.




May 8, 2017

Expert Discusses Unleashing Promise of Genetic Testing in Prostate Cancer

The Point Loma Rotary Club visited UCSD Medical School on Friday April 21, 2017 to present the proceeds from the annual Jim Krause Memorial Charity Bicycle Ride the Point 2016 event to MCC for pancreatic cancer research.




May 4, 2017

Amid uncertain future, California's stem cell agency loses transformative leader

Story features Sanford Stem Cell Clinical Center at UC San Diego Health.




April 28, 2017

Healthy living: Personalized cancer care

This week's healthy living takes a look at a new personalized way to treat people with cancer that's happening in San Diego.




April 20, 2017

For stem cell treatments, patients, doctors, scientists must collaborate

Stem cell research begins with scientists, passes on to physicians and ends up with patients. But those roles aren’t as separate as they seem, said speakers Thursday at a special meeting held by CIRM and UCSD, featuring Dr. Catriona Jamieson.




April 19, 2017

Rock Tour “Text2Give” Supports Immunotherapy at UC San Diego Health

After participating in an immunotherapy clinical trial at Moores Cancer Center at UC San Diego Health, Rock star Rikki Rockett of Poison was declared cancer-free in July 2016.




April 19, 2017

Dr. Kane on Genetic Testing for Prostate Cancer

Dr. Christopher Kane discusses the impact of genetic testing on patients with prostate cancer.




April 12, 2017

Frontline Cancer: Center for Novel Therapeutics to open in 2019 on UCSD campus

The 135,000-square-foot facility, located next to Moores Cancer Center on the east campus of UC San Diego, will house university scientists, local research organizations and biotech companies, all focused on cancer and related chronic diseases.




April 7, 2017

‘I don’t think people will believe me’: Researchers hesitated to share immunotherapy fears

Last week a study showing that immunotherapies may lead to rapid tumor growth in a small subset of patients met with some concern among oncologists and researchers. They worried that the news could dampen enthusiasm surrounding cancer’s most promising new therapy.




April 6, 2017

In Four Related Papers, Researchers Describe New and Improved Tools for Stem Cell Research

A large team of researchers led by senior author Kelly Frazer, PhD describes a new collection of 222 systematically derived and characterized iPSC lines generated as part of the National Heart, Lung and Blood Institute’s NextGen consortium.




March 2, 2017

Freenome announces $65 million in Series A funding, led by Andreessen Horowitz

Freenome is collaborating with Dr. Sandip Patel to develop non-invasive disease screenings for cancer.




February 21, 2017

Syros’ Drug Discovery Research in Immuno-Oncology Highlighted at UCSD

Pancreatic cancer therapy collaboration between Syros and Dr. Andy Lowy, presented at UCSD MCC Symposium.




February 16, 2017

UCSD cancer symposium unites a coalition

MCC Symposium presents 2017 Duane Roth Memorial Award, to CMO and EVP of pharmaceutical giant Roche/Genentech.




February 14, 2017

Cancer Survivor and Noted Physician-Scientist Sandra Horning to Receive Roth Award

The award will be presented at the annual MCC Translational Oncology Symposium.




February 6, 2017

Halozyme Internal Press Release

Halozyme CEO Dr. Helen Torley will present at the 13th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium. ➤




October 4, 2016

UC San Diego Health Joins Precision Medicine Initiative to Tackle Pancreatic Cancer

Precision Promise brings together researchers, clinicians and drug developers, led by Dr. Andy Lowy.




May 20, 2016

Accelerated tech transfer between the drugmaker and the academic institution

The UCSD MCC and GSK collaboration is entitled "Discovery Partnerships with Academia" or DPAc. The May 2016 Technology Transfer Tactics issue interviews MCC Director of Industry Relations Ida Deichaite, PhD on page 70.




May 2, 2016

UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License

Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed an agreement with UC San Diego to commercialize antibodies.




February 24, 2016

Emphasizing Collaboration at a Pivotal Moment in Cancer Research

MCC Director of Industry Relations Ida Deichaite, PhD's opinion article features the current cancer therapy landscape including the Cancer Moonshot and MCC symposium.




» More Press